Expression of Fas and Fas-related molecules in human hepatocellular carcinoma
- 1 March 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (3) , 250-256
- https://doi.org/10.1053/hupa.2001.22769
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?Journal of Clinical Investigation, 1997
- Apoptosis by Death FactorCell, 1997
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell linesJournal of Hepatology, 1996
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.The Journal of Experimental Medicine, 1995
- FAP-1: A Protein Tyrosine Phosphatase That Associates with FasScience, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- Monoclonal Antibody-Mediated Tumor Regression by Induction of ApoptosisScience, 1989
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.The Journal of Experimental Medicine, 1989